NCT03250299 2024-06-24Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaBasilea PharmaceuticaPhase 1 Terminated26 enrolled 17 charts
NCT02587819 2016-04-14Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% OintmentBiosceptrePhase 1 Completed21 enrolled 9 charts